Biocartis Group NV (BCART.BR) Fundamental Analysis & Valuation

EBR:BCART • BE0974281132

Current stock price

0.29 EUR
+0.01 (+1.75%)
Last:

This BCART.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BCART.BR Profitability Analysis

1.1 Basic Checks

  • In the past year BCART has reported negative net income.
  • In the past year BCART has reported a negative cash flow from operations.
BCART.BR Yearly Net Income VS EBIT VS OCF VS FCFBCART.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

  • The profitability ratios for BCART are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCART.BR Yearly ROA, ROE, ROICBCART.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 100 -100 200

1.3 Margins

  • BCART has a Gross Margin (48.16%) which is in line with its industry peers.
  • BCART's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BCART so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y-3.85%
BCART.BR Yearly Profit, Operating, Gross MarginsBCART.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BCART.BR Health Analysis

2.1 Basic Checks

  • BCART does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BCART has been increased compared to 1 year ago.
  • BCART has a better debt/assets ratio than last year.
BCART.BR Yearly Shares OutstandingBCART.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
BCART.BR Yearly Total Debt VS Total AssetsBCART.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -5.89, we must say that BCART is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BCART (-5.89) is worse than 94.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.89
ROIC/WACCN/A
WACC5.17%
BCART.BR Yearly LT Debt VS Equity VS FCFBCART.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.65 indicates that BCART should not have too much problems paying its short term obligations.
  • The Current ratio of BCART (1.65) is comparable to the rest of the industry.
  • BCART has a Quick Ratio of 1.20. This is a normal value and indicates that BCART is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.20, BCART is in line with its industry, outperforming 48.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.2
BCART.BR Yearly Current Assets VS Current LiabilitesBCART.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BCART.BR Growth Analysis

3.1 Past

  • The earnings per share for BCART have decreased by -1.55% in the last year.
  • The Revenue has grown by 19.08% in the past year. This is quite good.
  • BCART shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.36% yearly.
EPS 1Y (TTM)-1.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.11%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y15.36%
Revenue growth 5Y22.36%
Sales Q2Q%17.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.29% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BCART will show a very strong growth in Revenue. The Revenue will grow by 21.39% on average per year.
EPS Next Y36%
EPS Next 2Y31.91%
EPS Next 3Y24.29%
EPS Next 5YN/A
Revenue Next Year3.76%
Revenue Next 2Y16.6%
Revenue Next 3Y21.39%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BCART.BR Yearly Revenue VS EstimatesBCART.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BCART.BR Yearly EPS VS EstimatesBCART.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. BCART.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BCART. In the last year negative earnings were reported.
  • Also next year BCART is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCART.BR Price Earnings VS Forward Price EarningsBCART.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCART.BR Per share dataBCART.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • BCART's earnings are expected to grow with 24.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.91%
EPS Next 3Y24.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BCART.BR Dividend Analysis

5.1 Amount

  • No dividends for BCART!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BCART.BR Fundamentals: All Metrics, Ratios and Statistics

Biocartis Group NV

EBR:BCART (9/22/2023, 7:00:00 PM)

0.29

+0.01 (+1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.24M
Revenue(TTM)57.48M
Net Income(TTM)-65.38M
Analysts84.44
Price Target1.12 (286.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-60%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.61
BVpS-0.32
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.16%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y-3.85%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.48%
Cap/Sales 3.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.2
Altman-Z -5.89
F-Score4
WACC5.17%
ROIC/WACCN/A
Cap/Depr(3y)29.2%
Cap/Depr(5y)49.97%
Cap/Sales(3y)6.05%
Cap/Sales(5y)9.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.11%
EPS Next Y36%
EPS Next 2Y31.91%
EPS Next 3Y24.29%
EPS Next 5YN/A
Revenue 1Y (TTM)19.08%
Revenue growth 3Y15.36%
Revenue growth 5Y22.36%
Sales Q2Q%17.8%
Revenue Next Year3.76%
Revenue Next 2Y16.6%
Revenue Next 3Y21.39%
Revenue Next 5YN/A
EBIT growth 1Y24.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.9%
EBIT Next 3Y29.4%
EBIT Next 5YN/A
FCF growth 1Y32.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.74%
OCF growth 3YN/A
OCF growth 5YN/A

Biocartis Group NV / BCART.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Biocartis Group NV (BCART.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BCART.BR.


Can you provide the valuation status for Biocartis Group NV?

ChartMill assigns a valuation rating of 1 / 10 to Biocartis Group NV (BCART.BR). This can be considered as Overvalued.


How profitable is Biocartis Group NV (BCART.BR) stock?

Biocartis Group NV (BCART.BR) has a profitability rating of 0 / 10.


How financially healthy is Biocartis Group NV?

The financial health rating of Biocartis Group NV (BCART.BR) is 2 / 10.